147 related articles for article (PubMed ID: 30985385)
1. Attention-Deficit Hyperactivity Disorder in Pediatric Patients With Type 1 Diabetes Mellitus: Clinical Outcomes and Diabetes Control.
Vinker-Shuster M; Golan-Cohen A; Merhasin I; Merzon E
J Dev Behav Pediatr; 2019 Jun; 40(5):330-334. PubMed ID: 30985385
[TBL] [Abstract][Full Text] [Related]
2. Glycemic Control and Diabetes Related Complications in Adults with Type 1 Diabetes Mellitus and ADHD.
Vinker-Shuster M; Eldor R; Green I; Golan-Cohen A; Manor I; Merzon E
J Atten Disord; 2022 Jul; 26(9):1235-1244. PubMed ID: 34933573
[TBL] [Abstract][Full Text] [Related]
3. Comorbidity of attention deficit hyperactivity disorder and type 1 diabetes in children and adolescents: Analysis based on the multicentre DPV registry.
Hilgard D; Konrad K; Meusers M; Bartus B; Otto KP; Lepler R; Schober E; Bollow E; Holl RW;
Pediatr Diabetes; 2017 Dec; 18(8):706-713. PubMed ID: 27523391
[TBL] [Abstract][Full Text] [Related]
4. Dual diagnosis of type 1 diabetes mellitus and attention deficit hyperactivity disorder.
Mazor-Aronovitch K; Pinhas-Hamiel O; Pivko-Levy D; Modan-Moses D; Levek N; Miller S; Yackobovitch-Gavan M; Gruber N; Ben-Ami M; Stern E; Ben-Ari T; Graf-Barel C; Frumkin Ben-David R; Levy-Shraga Y; Landau Z
Pediatr Diabetes; 2021 Jun; 22(4):649-655. PubMed ID: 33651452
[TBL] [Abstract][Full Text] [Related]
5. The effect of attention deficit/hyperactivity disorder and other psychiatric disorders on the treatment of pediatric diabetes mellitus.
Yazar A; Akın F; Akça ÖF; Eklioğlu BS; Türe E; Coşkun F; Atabek ME
Pediatr Diabetes; 2019 May; 20(3):345-352. PubMed ID: 30652399
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls.
Coghill D; Hodgkins P
Eur Child Adolesc Psychiatry; 2016 Mar; 25(3):261-71. PubMed ID: 26054300
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of medically treated children with ADHD and type 1 diabetes in Germany - Analysis of two representative databases.
Kapellen TM; Reimann R; Kiess W; Kostev K
J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1293-1297. PubMed ID: 27754966
[TBL] [Abstract][Full Text] [Related]
8. Previously undiagnosed attention-deficit/hyperactivity disorder associated with poor metabolic control in adolescents with type 1 diabetes.
Nylander C; Lindström K; Khalifa N; Fernell E
Pediatr Diabetes; 2018 Jun; 19(4):816-822. PubMed ID: 29575401
[TBL] [Abstract][Full Text] [Related]
9. Association of attention deficit hyperactivity disorder with recurrent hypoglycemia in type 1 diabetes mellitus.
Lin SY; Lin CL; Hsu WH; Lin CC; Fu YC
Pediatr Diabetes; 2019 Mar; 20(2):189-196. PubMed ID: 29938875
[TBL] [Abstract][Full Text] [Related]
10. Emergency department use and costs for youth with attention-deficit/hyperactivity disorder: associations with stimulant treatment.
Leibson CL; Barbaresi WJ; Ransom J; Colligan RC; Kemner J; Weaver AL; Katusic SK
Ambul Pediatr; 2006; 6(1):45-53. PubMed ID: 16443183
[TBL] [Abstract][Full Text] [Related]
11. Attention-Deficit/Hyperactivity Disorder in 2- to 5-Year-Olds: A Primary Care Network Experience.
Bannett Y; Feldman HM; Gardner RM; Blaha O; Huffman LC
Acad Pediatr; 2021 Mar; 21(2):280-287. PubMed ID: 32360494
[TBL] [Abstract][Full Text] [Related]
12. Risk of Type 2 Diabetes in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder: A Nationwide Longitudinal Study.
Chen MH; Pan TL; Hsu JW; Huang KL; Su TP; Li CT; Lin WC; Tsai SJ; Chang WH; Chen TJ; Bai YM
J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29727071
[TBL] [Abstract][Full Text] [Related]
13. ADHD Treatment in Primary Care: Demographic Factors, Medication Trends, and Treatment Predictors.
Hauck TS; Lau C; Wing LLF; Kurdyak P; Tu K
Can J Psychiatry; 2017 Jun; 62(6):393-402. PubMed ID: 28103079
[TBL] [Abstract][Full Text] [Related]
14. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.
Song I; Lee MS; Lee EK; Shin JY
Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 28631372
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
16. Descriptive comparison of drug treatment-persistent, -nonpersistent, and nondrug treatment patients with newly diagnosed attention deficit/hyperactivity disorder in Germany.
Braun S; Russo L; Zeidler J; Linder R; Hodgkins P
Clin Ther; 2013 May; 35(5):673-85. PubMed ID: 23587606
[TBL] [Abstract][Full Text] [Related]
17. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
[TBL] [Abstract][Full Text] [Related]
18. The effect of methylphenidate treatment on psychopathic behavior of patients having attention-deficit hyperactivity disorder with and without oppositional defiant disorder.
Golubchik P; Levy T; Weizman A
Int Clin Psychopharmacol; 2018 Nov; 33(6):330-333. PubMed ID: 29958238
[TBL] [Abstract][Full Text] [Related]
19. When does it end? Attention-deficit/hyperactivity disorder in the middle aged and older populations.
Manor I; Rozen S; Zemishlani Z; Weizman A; Zalsman G
Clin Neuropharmacol; 2011; 34(4):148-54. PubMed ID: 21738027
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, incidence, and stimulant use of attention-deficit hyperactivity disorder in Taiwan, 1996-2005: a national population-based study.
Chien IC; Lin CH; Chou YJ; Chou P
Soc Psychiatry Psychiatr Epidemiol; 2012 Dec; 47(12):1885-90. PubMed ID: 22476209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
